NEXENTIS TECHNOLOGIES INC. Debt Securities, Unrealized Gain (Loss)
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Debt Securities, Unrealized Gain (Loss) of -$970.50 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesUnrealizedGainLoss · last filed 2024-11-14
- NEXENTIS TECHNOLOGIES INC. debt securities, unrealized gain (loss) for the quarter ending 2024-09-30 was -$970.50K.
- NEXENTIS TECHNOLOGIES INC. debt securities, unrealized gain (loss) for the quarter ending 2024-06-30 was $29.73K.
- NEXENTIS TECHNOLOGIES INC. debt securities, unrealized gain (loss) for the quarter ending 2024-03-31 was $83.94K.
- NEXENTIS TECHNOLOGIES INC. debt securities, unrealized gain (loss) for the quarter ending 2023-12-31 was -$626.02K.
- NEXENTIS TECHNOLOGIES INC. debt securities, unrealized gain (loss) for fiscal 2023 was -$713.59K.
| Period end | Debt Securities, Unrealized Gain (Loss) 3 month | Debt Securities, Unrealized Gain (Loss) 6 month | Debt Securities, Unrealized Gain (Loss) 9 month | Debt Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$970.50K 10-Q · filed 2024-11-14 | -$940.78K derived: sum of 2 quarters · filed 2024-11-14 | -$856.84K 10-Q · filed 2024-11-14 | -$1.48M derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | $29.73K 10-Q · filed 2024-08-14 | $113.67K 10-Q · filed 2024-08-14 | -$512.35K derived: sum of 3 quarters · filed 2024-08-14 | -$702.03K derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-03-31 | $83.94K 10-Q · filed 2024-05-15 | -$542.07K derived: sum of 2 quarters · filed 2024-05-15 | -$731.76K derived: sum of 3 quarters · filed 2024-11-14 | |
| 2023-12-31 | -$626.02K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$815.70K derived: sum of 2 quarters · filed 2024-11-14 | -$713.59K 10-K · filed 2024-04-01 | |
| 2023-09-30 | -$189.68K 10-Q · filed 2024-11-14 | -$87.58K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |